Shopping Cart 0
Cart Subtotal
USD 0

Peripherally Inserted Central Catheter (PICC) - Medical Devices Pipeline Assessment, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Peripherally Inserted Central Catheter (PICC)-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Peripherally Inserted Central Catheter (PICC)-Medical Devices Pipeline Assessment, 2018 provides an overview of Peripherally Inserted Central Catheter (PICC) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripherally Inserted Central Catheter (PICC) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Peripherally Inserted Central Catheter (PICC) under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Peripherally Inserted Central Catheter (PICC) and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Peripherally Inserted Central Catheter (PICC) under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 Peripherally Inserted Central Catheter (PICC) Overview 5

3 Products under Development 6

3.1 Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Stage of Development 6

3.2 Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Territory 7

3.3 Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Regulatory Path 8

3.4 Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Estimated Approval Date 9

4 Peripherally Inserted Central Catheter (PICC)-Pipeline Products under Development by Companies 10

4.1 Peripherally Inserted Central Catheter (PICC) Companies-Pipeline Products by Stage of Development 10

4.2 Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Stage of Development 11

5 Peripherally Inserted Central Catheter (PICC) Companies and Product Overview 12

5.1 AngioDynamics Inc Company Overview 12

5.1.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 12

5.2 C. R. Bard Inc Company Overview 14

5.2.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 14

5.3 Guerbet LLC Company Overview 16

5.3.1 Guerbet LLC Pipeline Products & Ongoing Clinical Trials Overview 16

5.4 Silmag SA Company Overview 18

5.4.1 Silmag SA Pipeline Products & Ongoing Clinical Trials Overview 18

5.5 Tel Aviv University Company Overview 21

5.5.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 University of Texas Health Science Center at Houston Company Overview 22

5.6.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 22

6 Peripherally Inserted Central Catheter (PICC)-Recent Developments 23

6.1 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value 23

6.2 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 23

6.3 May 23, 2018: Access Scientific Completes Study Demonstrating Superior Anti-Thrombotic Properties of POWERWAND Midlines and Extended Dwell Catheters 26

6.4 May 17, 2018: Guerbet strengthens its leadership in innovative interventional radiology with the launch of two new microcatheters 26

6.5 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives 27

6.6 May 09, 2018: ICU Medical Announces First Quarter 2018 Results 28

6.7 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 29

6.8 May 03, 2018: Teleflex Reports First Quarter 2018 Results 29

6.9 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 32

6.10 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 32

6.11 Mar 29, 2018: AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results 33

6.12 Mar 22, 2018: Access Scientific announces discovery of the cause of POWERWAND catheters' ZERO bloodstream infections in over 35,000 catheter-days of published use 34

6.13 Mar 01, 2018: ICU Medical Announces Fourth Quarter and Fiscal Year 2017 Results 35

6.14 Feb 22, 2018: Access Vascular Receives FDA Clearance for its HydroPICC Catheter 36

6.15 Feb 22, 2018: Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance 37

6.16 Feb 05, 2018: Zyno Solutions Names Steve Watkins As General Manager And Executive Vice President 39

6.17 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 39

6.18 Jan 04, 2018: AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results 40

6.19 Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition 41

6.20 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 42

6.21 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 43

6.22 Nov 09, 2017: ICU Medical Announces Third Quarter 2017 Results 46

6.23 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 46

6.24 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 47

6.25 Nov 02, 2017: Teleflex Reports Third Quarter 2017 Results 48

6.26 Oct 25, 2017: Bard Announces Third Quarter Results 50

6.27 Oct 24, 2017: POWERWAND Midline IV Catheter Achieves 23,000 Catheter Days with Zero Bloodstream Infections 52

6.28 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 52

6.29 Sep 28, 2017: AngioDynamics Reports Fiscal 2018 First Quarter Results 53

6.30 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California 55

6.31 Sep 14, 2017: Outcomes in a Nurse-Led Peripherally Inserted Central Catheter Program: A Retrospective Cohort Study Published in CMAJ Open 55

6.32 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 56

6.33 Aug 09, 2017: ICU Medical Announces Second Quarter 2017 Results 59

6.34 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results 59

6.35 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results 61

6.36 Jun 23, 2017: Vygon wins an international Business award for safe-enteral.com 63

7 Appendix 64

7.1 Methodology 64

7.2 About GlobalData 67

7.3 Contact Us 67

7.4 Disclaimer 67


List Of Figure

1.2 List of Figures

Figure 1: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Stage of Development 6

Figure 2: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Territory 7

Figure 3: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Regulatory Path 8

Figure 4: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Estimated Approval Date 9


List Of Table

1.1 List of Tables

Table 1: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Stage of Development 6

Table 2: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Territory 7

Table 3: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Regulatory Path 8

Table 4: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Estimated Approval Date 9

Table 5: Peripherally Inserted Central Catheter (PICC) Companies-Pipeline Products by Stage of Development 10

Table 6: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Stage of Development 11

Table 7: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 12

Table 8: BioFlo PICC Line Extension-Product Status 12

Table 9: BioFlo PICC Line Extension-Product Description 12

Table 10: Next Generation BioFlo PICC-Product Status 13

Table 11: Next Generation BioFlo PICC-Product Description 13

Table 12: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 14

Table 13: Anti-Thrombotic PICCs-Product Status 14

Table 14: Anti-Thrombotic PICCs-Product Description 14

Table 15: Antimicrobial PICC-Product Status 15

Table 16: Antimicrobial PICC-Product Description 15

Table 17: COVERT PowerPICC-Product Status 15

Table 18: COVERT PowerPICC-Product Description 15

Table 19: Guerbet LLC Pipeline Products & Ongoing Clinical Trials Overview 16

Table 20: DraKon-Product Status 16

Table 21: DraKon-Product Description 16

Table 22: SeQure-Product Status 17

Table 23: SeQure-Product Description 17

Table 24: Silmag SA Pipeline Products & Ongoing Clinical Trials Overview 18

Table 25: PICC Intravenous Canalization Catheter-Product Status 18

Table 26: PICC Intravenous Canalization Catheter-Product Description 18

Table 27: PICC Percutaneous Catheter With Peel Off Introducer-Product Status 19

Table 28: PICC Percutaneous Catheter With Peel Off Introducer-Product Description 19

Table 29: PICC Percutaneous Catheter With Peel Off Introducer (Double Lumen)-Product Status 19

Table 30: PICC Percutaneous Catheter With Peel Off Introducer (Double Lumen)-Product Description 20

Table 31: Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 21

Table 32: Short Peripheral Infusion Catheter-Product Status 21

Table 33: Short Peripheral Infusion Catheter-Product Description 21

Table 34: University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 22

Table 35: Automated Catheter Insertion System-Product Status 22

Table 36: Automated Catheter Insertion System-Product Description 22

Table 37: Glossary 66

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

AngioDynamics Inc, BioFlo PICC Line Extension; AngioDynamics Inc, Next Generation BioFlo PICC; C. R. Bard Inc, Antimicrobial PICC; C. R. Bard Inc, Anti-Thrombotic PICCs; C. R. Bard Inc, COVERT PowerPICC; Guerbet LLC, DraKon; Guerbet LLC, SeQure; Silmag SA, PICC Intravenous Canalization Catheter; Silmag SA, PICC Percutaneous Catheter With Peel Off Introducer; Silmag SA, PICC Percutaneous Catheter With Peel Off Introducer (Double Lumen); Tel Aviv University, Short Peripheral Infusion Catheter; University of Texas Health Science Center at Houston, Automated Catheter Insertion System


Companies

AngioDynamics Inc

C. R. Bard Inc

Guerbet LLC

Silmag SA

Tel Aviv University

University of Texas Health Science Center at Houston